{
}
Deutsche Bank has raised its price target for Novartis shares to CHF115 from CHF110, maintaining a Buy rating, driven by optimism surrounding the cancer treatment Pluvicto's label expansion. The company shows strong financial health with a 10.85% revenue growth and a gross profit margin of 75.22%. In contrast, UBS downgraded Novartis from Buy to Neutral, lowering the target to CHF104, citing concerns over upcoming patent expirations that may hinder growth.
GSK reported a strong fiscal year with a 7% increase in currency-adjusted revenue, reaching £31 billion, driven by growth in cancer treatments and innovative medicines. The company raised its sales targets to 2031 and announced a £2 billion share buyback over the next 18 months. Analysts have varied ratings for GSK, with Bernstein maintaining an 'Outperform' at a target of 2355 pence, while Deutsche Bank holds a 'Hold' rating with a target of 1450 pence.
Deutsche Bank analyst Emmanuel Papadakis upgraded Sanofi's stock from Sell to Hold, raising the price target to €100.00 from €85.00, following strong fourth-quarter results that indicated solid growth and reduced risks. The upgrade reflects improved sentiment towards Sanofi's strategy, particularly with the positive performance of Dupixent in the COPD market, and a clarified buyback program that alleviated merger concerns. Investors may interpret this as a sign of Sanofi's stability and potential for sustained growth.
Novo Nordisk's shares plummeted over 21% following disappointing results from the Phase 3 trial of its obesity drug CagriSema, which achieved a 22.7% average weight reduction, falling short of the expected 25%. Analysts have reacted with downgrades, citing safety concerns and underperformance compared to competitors. Despite achieving primary study objectives, the market's response reflects significant investor disappointment.
Health stocks fell sharply after President-elect Trump nominated vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. The S&P 500 Health Care Index dropped 1.9%, with major companies like Moderna and Pfizer seeing significant losses. Analysts warn that Kennedy's views could undermine vaccine confidence and impact the biotechnology sector, leading to potential public health risks.
Health stocks have plummeted following Donald Trump's appointment of vaccine skeptic Robert F. Kennedy Jr. as health secretary, with Moderna, Pfizer, and GSK experiencing significant losses. The decline has affected US-exposed European healthcare stocks as well, amid growing uncertainty in the vaccine industry. Analysts have downgraded their outlooks on vaccine stocks, reflecting concerns over Kennedy's stance on vaccines and potential policy changes.
Emmanuel Papadakis
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Deutsche Bank raises Novartis price target amid Pluvicto optimism
13:47 03.04.2025
gsk reports strong year-end results and raises sales targets to 2031
British Pound Sterling
Glaxosmithkline plc
CHN
USA
GBR
James Gordon
Luisa Hector
Emmanuel Papadakis
Peter Welford
Rajan Sharma
Florent Cespedes
Show more
07:14 06.02.2025
Deutsche Bank upgrades Sanofi stock to hold with increased price target
13:24 31.01.2025
novo nordisk faces stock plunge after disappointing results for obesity drug
Danish Krone
Catalent, Inc.
Novo Nordisk A/S
Eli Lilly and Company
DNK
Florent Cespedes
Emmanuel Papadakis
Jo Walton
Peter Welford
Show more
15:35 20.12.2024
health stocks decline after trump nominates vaccine skeptic robert f kennedy jr
United States Dollar
Sanofi
Eli Lilly and Company
GSK plc
Novo Nordisk A/S
Roche Holding AG
Pfizer Inc.
USA
GBR
FRA
Brian Abrahams
Robert F. Kennedy Jr.
Michael Yee
Emmanuel Papadakis
Show more
22:25 15.11.2024
health stocks plunge after trump appoints vaccine skeptic as health secretary
Moderna, Inc.
Novavax, Inc.
GSK plc
Novo Nordisk A/S
Pfizer Inc.
Hoffmann-La Roche AG
USA
Robert F. Kennedy Jr.
Donald Trump
Emmanuel Papadakis
Show more
19:16 15.11.2024
Trending
Subcategory
Industry Trends
Corporate News
Supply Chain Management
Startups & Entrepreneurship
Global Trade Developments
Government Economic Policies
Industry Mergers & Acquisitions
Retail and Consumer Goods
Finance Mergers & Acquisitions
Financial Scams and Security
Fintech Startups
Emerging Startups
Workplace Trends
Venture Capital Investments
Cryptocurrency Trends
Funding Rounds & Investments
Energy Sector Developments
CEO Changes
Market Analysis and Predictions
Stock Market Updates
Countries:
Companies:
Apple Inc.
Google Inc.
NVIDIA Corporation
Delhivery Limited
Ecom Express Ltd.
Alphabet Inc.
OpenAI ERC USD
Ciscom Corp.
ERICSSON - CLASS B
Physicswallah Ltd.
Learning Resources Inc.
MGA Entertainment Inc.
State Street Global Advisors Luxembourg SICAV - SSGA EMU ESG Screened Equity Fund
Snap Inc.
Tiktok USD
Semiconductor Manufacturing International Corporation
Hua Hong Semiconductor Ltd.
Spotify Technology S.A.
Dropbox, Inc.
Vimeo, Inc.
Currencies:
United States Dollar
Indian Rupee
Chinese Yuan
Euro
Vietnamese Đồng
New Taiwan Dollar
United Arab Emirates Dirham
Russian Ruble
South Korean Won
Pakistani Rupee
Algerian Dinar
Australian Dollar
Thai Baht
Japanese Yen
Saudi Riyal
People:
Donald Trump
Ilya Sutskever
Peter Thiel
Amal El Fallah Seghrouchni
Trixie Lohmirmand
Scott Bessent
Jamieson Greer
Joe Jurken
Stephen Roachford
David French
Rick Woldenberg
Marc Rosenberg
Isaac Larian
Hichem Djouhri
Laurina Emmanuel
Tim Cook
Andrew Ferguson
Sheryl Sandberg
Mark Zuckerberg
Pavel Prass